Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06614348

Prednisolone Acetate Eye Drops for Pain Intervention in Second Eye Cataract Surgery

A Randomized Controlled Study of Prednisolone Acetate Eye Drops for Pain Intervention in Second Eye Cataract Surgery

Status
Not Yet Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Academic / Other
Sex
All
Age
50 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study aims to evaluate the efficacy, safety, and potential mechanisms of prednisolone acetate eye drops for pain management in patients undergoing second-eye surgery for age-related cataracts. Researchers will compare prednisolone acetate eye drops to sodium hyaluronate eye drops to see if prednisolone acetate eye drops work to relieve intraoperative and postoperative pain during second-eye cataract surgery. Participants will: 1. Receive prednisolone acetate eye drops or sodium hyaluronate eye drop four drops within 2 hours before cataract surgery 2. Finish cataract surgery and routine postoperative follow-up 3. Pain questionnaire completed after cataract surgery

Conditions

Interventions

TypeNameDescription
DRUGPrednisolone acetate eye drop groupPatients receive prednisolone acetate eye drops 4 times per 30min within 2 hours before cataract surgery
DRUGSodium hyaluronate eye dropsPatients receive sodium hyaluronate eye drops 4 times per 30min within 2 hours before cataract surgery

Timeline

Start date
2024-10-08
Primary completion
2025-06-30
Completion
2025-11-30
First posted
2024-09-26
Last updated
2024-09-26

Source: ClinicalTrials.gov record NCT06614348. Inclusion in this directory is not an endorsement.